Pfizer, Inc.
PFEPharmaceuticals
$29.95+1.70%As of Oct 29vs prior close
- Market cap
- $170.7B
- P/E (TTM)
- 38.9×
- P/E (FY1)
- 10.1×
- From 52W high
- −1.55%
- EPS (LTM)
- $0.76
- Revenue (LTM)
- $63.7B
- Net margin
- 6.80%
- Dividend yield
- 5.74%
Nomior Score
51
Steady ProfileTop 49% of the scored universe
Growth12
Quality47
Value68
Momentum81
Resilience49
Growth
+1.90%revenue a year over 9 fiscal years
YE16 $52.8BLTM $63.7B
Connections
Revenue to profitQ2 YE26
The net loss was 2% of revenue, wider by 22 pts on a year.
Who owns it
6funds, 10 tracked portfolios